Wikidata

(Q63597295)

English

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

clinical trial

In more languages

Statements

title
Medroxyprogesterone Acetate (MPA) Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia (English)
0 references
sponsor
Xiaojun Chen
0 references
start time
1 October 2018
0 references
end time
30 September 2020
0 references
number of participants
460
0 references
minimum age
18 year
0 references
maximum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63597295&oldid=1857343869"